RESPIVAX

Veterinary preparations, namely, vaccines, oral and injectable antimicrobial preparations for the treatment of bovine respiratory disease, infectious bovine rhinotracheitis (IBR), bovine viral diarrhea (BVD 1 and BVD 2), bovine respiratory syncytial virus (BRSV), parainfluenza (PI3), pasteurella multocida, and mannheimia haemolytica; bacteriophage antimicrobials for the treatment of bovine respiratory disease, infectious bovine rhinotracheitis (IBR), bovine viral diarrhea (BVD 1 and BVD 2), bovine respiratory syncytial virus (BRSV), parainfluenza (PI3), pasteurella multocida, and mannheimia haemolytica; immunorestorative biopharmaceuticals for the treatment of bovine respiratory disease, infectious bovine rhinotracheitis (IBR), bovine viral diarrhea (BVD 1 and BVD 2), bovine respiratory syncytial virus (BRSV), parainfluenza (PI3), pasteurella multocida, and mannheimia haemolytica; parasiticides; insecticides; medicinal drugs for the treatment of bovine respiratory disease, infectious bovine rhinotracheitis (IBR), bovine viral diarrhea (BVD 1 and BVD 2), bovine respiratory syncytial virus (BRSV), parainfluenza (PI3), pasteurella multocida, and mannheimia haemolytica; dietary supplements; and hormone preparations